SS Innovations International, Inc. 8-K

What Happened

• SS Innovations International, Inc. (SSII) announced the appointment of Sarah M. Romano as its new Chief Financial Officer, effective August 3, 2026. The company filed a Current Report on Form 8-K to disclose the appointment and the related employment agreement.
• Ms. Romano, 46, has over 20 years of financial and public-company experience, most recently serving as CFO and Treasurer of Vicarious Surgical (Apr 2025–Jul 2026). She previously served as CFO at Entero Therapeutics (Mar 2022–Mar 2025) and Kiora Pharmaceuticals (Feb 2017–Feb 2022). She is a licensed CPA in Massachusetts and holds degrees from College of the Holy Cross and Boston College.

Key Details

• Effective date: August 3, 2026.
• Compensation: three-year employment agreement with an annual base salary of $440,000 and eligibility for an annual cash bonus tied to performance.
• Equity: grant of options to purchase 750,000 shares under the company’s 2026 Incentive Stock Plan, vesting 250,000 shares on the first anniversary and the remaining shares in 24 subsequent monthly installments (23 of 20,833 and a final 20,841), subject to continued employment.
• Agreement terms include customary confidentiality, proprietary rights assignment, non-competition and non-solicitation provisions, plus an indemnification agreement.

Why It Matters

• This is a material executive change (Item 5.02) that establishes the company’s new finance leader and may influence SSII’s financial reporting, budgeting, and capital strategy going forward.
• The salary, bonus opportunity and sizeable option grant are definite compensatory commitments that affect future cash outflows and potential equity dilution if options are exercised.
• Investors should note the effective date and review the filed employment agreement (Exhibit 10.1) and the company press release for full details on terms and any related governance provisions.